Highly active antiretroviral therapy (HAART) refers to a broad category of treatment regimens
usually comprised of three or more antiretroviral drugs that, in previously untreated HIV-1 …

Highly active antiretroviral therapy (HAART) has dramatically improved the prognosis of
patients with HIV, although it remains unclear as to the best time to start treatment to reduce …

The choice of initial antiretroviral regimen for treating people infected with HIV is crucial to
successful long-term control of virus replication. Potent antiretroviral therapy substantially …

When antiretroviral therapy first became available, it was hypothesized that the modest
clinical benefits seen in patients with advanced disease [1] would be more pronounced in …

Despite the success of highly active antiretroviral therapy (HAART) at reducing mortality from
HIV infection, there is evidence that it is not reaching the all of the population that needs it …

Human immunodeficiency virus type 2 (HIV-2), the second human retrovirus known to cause
AIDS, is endemic to West Africa but is infrequently found outside this region. We present a …

Background The efficacy of highly active antiretroviral therapy (HAART) in suppression of
HIV-1 is well documented. We investigated virological and clinical outcomes of HAART in …

Over the past 5 years, advances in human immunodeficiency virus type 1 (HIV-1) clinical
research and data on the effectiveness of potent combination therapy have substantially …

Highly active antiretroviral treatment (HAART) was given early to 64 patients with
symptomatic primary human immunodeficiency virus (HIV)-1 infection. At the time of …

Objective: To verify the effectiveness of highly active antiretroviral therapy (HAART) and to
identify any factors predictive of clinical outcome in a clinical setting. Design: Observational …